ARTHROGEN B.V.
Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. The first target indication is in the field of rheumatic diseases.
ARTHROGEN B.V.
Industry:
Biopharma Biotechnology
Founded:
2005-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.arthrogen.nl
Total Employee:
11+
Status:
Active
Contact:
+31.20.566.26.48
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content Cloudflare Hosting Person Schema Facebook Sharer Gravatar Profiles
Similar Organizations
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Current Employees Featured
Investors List
UvA Ventures Holding
UvA Ventures Holding investment in Seed Round - Arthrogen B.V.
Official Site Inspections
http://www.arthrogen.nl
- Host name: 172.67.138.177
- IP address: 172.67.138.177
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arthrogen B.V."
โ๏ธArthrogen BV โ Consulting Organization from the โฆ
Oct 11, 2024 Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โฆSee details»
Arthrogen BV - UvA Ventures
Dec 17, 2019 Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical โฆSee details»
Arthrogen B.V. - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +31.20.566.26.48 Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for โฆSee details»
Arthrogen Company Profile | Management and Employees List
Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โฆSee details»
Company Information - RocketReach
Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โฆSee details»
Arthrogen Company Profile 2024: Valuation, Investors โฆ
Arthrogen General Information Description. Developer of a local gene therapy intended for different indications, using viral-mediated gene transfer. The company specializes in the development of viral gene therapy vectors, in โฆSee details»
Arthrogen.nl
Wij gebruiken cookies om inhoud en advertenties te personaliseren, om functies voor sociale media aan te bieden en om ons verkeer te analyseren.See details»
Arthrogen B.V. - Amsterdam Life Sciences District
Arthrogen B.V. Arthrogen is developing local gene therapy for chronic diseases, using viral mediated gene transfer. ... 0205662648 โ Anouk Veneboer, Office manager: URL Company โฆSee details»
Arthrogen - Products, Competitors, Financials, Employees, โฆ
Arthrogen.nl. Overview & Products; People; About Arthrogen. Arthrogen is a biopharmaceutical company developing local gene therapy for different indications, using viral mediated gene โฆSee details»
Arthrogen BV - Amsterdam, Netherlands - bionity.com
Apr 3, 2006 Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. ... arthrogen.nl โฆSee details»
Arthrogen B.V. - Contacts, Employees, Board Members
Arthrogen B.V. is an Amsterdam based biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
Arthrogen - Overview, News & Similar companies | ZoomInfo.com
Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in Amsterdam, โฆSee details»
Arthrogen B.V. - Funding, Financials, Valuation & Investors
Nov 4, 2005 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Nov 4, 2005: โฆSee details»
Arthrogen BV - Amsterdam, Pays-Bas - bionity.com
Arthrogen.nl +31205662648. Partager. Xing Linkedin Facebook X E-mail Arthrogen BV. Meibergdreef 45 1105 BA Amsterdam Pays-Bas +31205662648. arthrogen.nl. Prendre โฆSee details»
Arthrogen - VentureRadar
Arthrogen, an Amsterdam based biopharmaceutical company, is developing local gene therapy for inflammatory diseases, using viral mediated gene transfer. The first target indication is in โฆSee details»
Arthrogen BV - HvA Ventures Holding
Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โฆSee details»
Arthrogen BV - biobank.co.kr
Biobank dB : Arthrogen BV, development of innovative local gene therapy for patients with rheumatoid arthritis ... Meibergdreef 45. 1105 BA Amsterdam Netherlands +31-20-566-26-48 โฆSee details»
Arthrogen BV - Amsterdam UMC Ventures Holding
Arthrogen BV. Arthrogen BV was founded in 2005 as a joint venture between the Dubai Bone & Joint Center (DBAJ) in the United Arab Emirates and the Academic Medical Center (AMC) in โฆSee details»
MeiraGTx Netherlands BV - Drug pipelines, Patents, Clinical
Explore MeiraGTx Netherlands BV with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 4 news, Drug:ART-I02, Recombinant adeno-associated viral vector based gene โฆSee details»
AAV5-CD39/CD73 (Arthrogen) - Drug Targets, Indications, Patents โฆ
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»